Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Strut Thickness for Patients Treated With Percutaneous Revascularization for Coronary Bifurcations: Insights From the BIFURCAT-ULTRA Registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

The Role of Serum Biomarkers for the Differential Diagnosis and Prognostic Assessment of Myocardial Infarction with Non-Obstructive Coronary Arteries: A Narrative Review.

Journal of clinical medicine·2026
Same author

Intracoronary Full Physiology and Imaging Unveiling a Rare Cause of MINOCA Presenting as Ventricular Fibrillation.

JACC. Case reports·2025
Same author

Drug-Coated Balloons in the European Registry of Chronic Total Occlusion: The ERCTO Registry.

JACC. Cardiovascular interventions·2025
Same author

Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR.

International journal of cardiology·2025
Same author

Ischaemic Stroke in Patients with Known Atrial Fibrillation: A Snapshot from a Large University Hospital Experience.

Journal of clinical medicine·2025

Related Experiment Video

Updated: Nov 19, 2025

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

624

The DESolve® novolimus bioresorbable scaffold.

Pierluigi Demola1, Francesco Meucci1, Miroslava Stolcova1

  • 1Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy.

Future Cardiology
|January 28, 2021
PubMed
Summary
This summary is machine-generated.

The DESolve scaffold offers a potential solution for coronary artery disease by providing temporary support and then dissolving, aiming to restore natural vessel function. This review explores its controversial yet promising role in interventional cardiology.

Keywords:
DESolvebioresorbable vascular scaffoldsbioresorptioncoronary artery diseasenovolimuspercutaneous coronary interventions

More Related Videos

Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant
07:28

Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant

Published on: September 7, 2016

11.7K
Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.7K

Related Experiment Videos

Last Updated: Nov 19, 2025

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:17

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

624
Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant
07:28

Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant

Published on: September 7, 2016

11.7K
Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.7K

Area of Science:

  • Interventional Cardiology
  • Biomaterials Science
  • Polymer Chemistry

Background:

  • Improving long-term outcomes of coronary stenting is a key goal.
  • Bioresorbable vascular scaffolds (BVS) initially showed promise but faced challenges.
  • Restoring native vessel patency and endothelial function remains critical.

Purpose of the Study:

  • To review the DESolve novolimus-eluting scaffold, a poly-L-lactide-based BVS.
  • To discuss its bio-reabsorption mechanism and complete dissolution within two years.
  • To evaluate its potential in addressing limitations of current coronary devices.

Main Methods:

  • Review of clinical data and scientific literature on the DESolve scaffold.
  • Analysis of its material properties (poly-L-lactide) and drug elution (novolimus).
  • Assessment of its mechanical support, self-correction properties, and safety margin for overexpansion.

Main Results:

  • DESolve provides necessary radial strength during the critical early post-implantation period.
  • It exhibits a unique self-correction property, reducing incomplete stent apposition.
  • The scaffold completely dissolves via bio-reabsorption within approximately two years.

Conclusions:

  • The DESolve scaffold represents a novel approach to coronary stenting with a bio-reabsorption mechanism.
  • Its temporary support and eventual dissolution aim to improve long-term vessel function.
  • Further evaluation is warranted for this controversial yet potentially revolutionary coronary device.